Cytheris, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.cytheris.com
Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant
Phase 1
Completed
- Conditions
- AMLCMLMDS
- Interventions
- Drug: CYT107 - Recombinant glycosylated human interleukin 7.Drug: rhIL-7 (CYT107)
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2012-07-26
- Lead Sponsor
- Cytheris, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00684008
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Institute, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath